ÂÜÀòÂÒÂ×

Dilbinder K Gill has extensive experience in the pharmaceutical and scientific research sectors, currently serving in the role of ATC Quality at Vertex Pharmaceuticals since January 2024. Previously, Dilbinder held the position of Senior Manager in Patient Supply Operations at Achilles Therapeutics plc from August 2022 to January 2024, and worked as a Senior Operations Scientist at Nature Metrics Ltd from December 2020 to July 2022. Prior to these roles, Dilbinder managed laboratory services and oversaw operations at Parexel and Parexel International. With a background in regulatory decisions at Human Tissue Authority and significant contributions to the International AIDS Vaccine Initiative at Imperial College London, Dilbinder has demonstrated leadership and expertise in various scientific and management capacities. Educational qualifications include a Ph.D. in Immunology from the University of Bedfordshire and an MSc in Biomedical Sciences from King's College London.